- Home
- RGLS vs YSXT Comparison
RGLS vs YSXT Comparison
Compare RGLS & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- YSXT
- Stock Information
- Founded
- RGLS 2007
- YSXT 2011
- Country
- RGLS United States
- YSXT China
- Employees
- RGLS N/A
- YSXT N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- YSXT Automotive Aftermarket
- Sector
- RGLS Health Care
- YSXT Consumer Discretionary
- Exchange
- RGLS Nasdaq
- YSXT Nasdaq
- Market Cap
- RGLS 102.1M
- YSXT 87.9M
- IPO Year
- RGLS 2012
- YSXT 2024
- Fundamental
- Price
- RGLS $1.55
- YSXT $4.11
- Analyst Decision
- RGLS Strong Buy
- YSXT
- Analyst Count
- RGLS 6
- YSXT 0
- Target Price
- RGLS $10.33
- YSXT N/A
- AVG Volume (30 Days)
- RGLS 268.2K
- YSXT 283.1K
- Earning Date
- RGLS 11-07-2024
- YSXT 01-01-0001
- Dividend Yield
- RGLS N/A
- YSXT N/A
- EPS Growth
- RGLS N/A
- YSXT N/A
- EPS
- RGLS N/A
- YSXT 0.21
- Revenue
- RGLS N/A
- YSXT $58,546,729.00
- Revenue This Year
- RGLS N/A
- YSXT N/A
- Revenue Next Year
- RGLS N/A
- YSXT N/A
- P/E Ratio
- RGLS N/A
- YSXT $16.86
- Revenue Growth
- RGLS N/A
- YSXT 18.92
- 52 Week Low
- RGLS $1.08
- YSXT $2.54
- 52 Week High
- RGLS $3.79
- YSXT $6.27
- Technical
- Relative Strength Index (RSI)
- RGLS 49.06
- YSXT N/A
- Support Level
- RGLS $1.49
- YSXT N/A
- Resistance Level
- RGLS $1.62
- YSXT N/A
- Average True Range (ATR)
- RGLS 0.11
- YSXT 0.00
- MACD
- RGLS -0.00
- YSXT 0.00
- Stochastic Oscillator
- RGLS 37.50
- YSXT 0.00
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.